Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/07/519   
Active ingredient: Maribavir
Indication: Prevention of cytomegalovirus (CMV) disease in patients with impaired cell mediated immunity deemed at risk
Sponsor: ViroPharma SPRL-BVBA
rue Montoyer 47, 1000 Bruxelles, Belgique / Montoyerstraat 47, 1000 Brussel, BelgiŽ

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/12/2007 Centralised Orphan - Designation EMEA/OD/067/07 (2007)6799 of 18/12/2007
21/07/2008 Other procedure EMEA/OD/067/07
21/07/2008 Other procedure
24/02/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/067/07/T/01 (2009)1274 of 20/02/2009
18/12/2009 Other procedure
17/03/2011 Other procedure EMEA/OD/067/07